Naltrexone HCl: A Clinically Validated Solution for Alcohol Dependence
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $7.18 | $215.49 (0%) | 🛒 Add to cart |
| 60 | $6.80 | $430.97 $407.81 (5%) | 🛒 Add to cart |
| 90 | $6.66
Best per pill | $646.46 $599.13 (7%) | 🛒 Add to cart |
Synonyms | |||
Naltrexone Hydrochloride is an opioid antagonist medication approved by the FDA for the management of alcohol use disorder (AUD). It functions by binding to opioid receptors in the brain, effectively reducing the euphoric effects and cravings associated with alcohol consumption. This pharmacological intervention is a cornerstone of Medication-Assisted Treatment (MAT), designed to be used as part of a comprehensive treatment plan that includes counseling and behavioral therapies. By mitigating the reinforcing properties of alcohol, it supports patients in maintaining abstinence and reducing heavy drinking days, thereby facilitating long-term recovery.
Features
- Active Ingredient: Naltrexone Hydrochloride
- Available Formulations: 50 mg oral tablets and extended-release injectable suspension (380 mg/vial)
- Mechanism of Action: Competitive antagonist at μ-opioid receptors
- Bioavailability: Oral: 5–40% (extensive first-pass metabolism); Injectable: Sustained release over approximately 4 weeks
- Half-life: Oral: 4–13 hours; Injectable: 5–10 days (release phase)
- Metabolism: Primarily hepatic, via dihydrodiol dehydrogenase
- Excretion: Primarily renal (urine)
Benefits
- Significantly reduces the frequency of heavy drinking episodes.
- Diminishes the subjective pleasurable effects of alcohol, weakening its reinforcing properties.
- Aids in the prevention of relapse to alcohol dependence following detoxification.
- Supports long-term abstinence when combined with psychosocial support.
- Provides a non-addictive pharmacological option for sustained management.
- The extended-release formulation ensures consistent plasma levels, improving adherence.
Common use
Naltrexone HCl is indicated for use in adults as part of a comprehensive treatment program for alcohol dependence. It is prescribed after the patient has undergone successful detoxification and achieved initial abstinence. It is suitable for patients who are motivated to remain in treatment and adhere to a sobriety plan, often utilized in both outpatient and inpatient settings under medical supervision.
Dosage and direction
- Oral Tablets: The recommended dose is 50 mg once daily, with or without food. Treatment should be initiated by a healthcare provider following opioid-free status confirmation.
- Extended-Release Injection: 380 mg delivered intramuscularly gluteally once every 4 weeks, alternating buttocks for subsequent injections. Must be administered by a healthcare professional.
- Dosage adjustments are generally not required for oral administration. Adherence to the prescribed regimen is critical for efficacy.
Precautions
- Patients should be opioid-free for a minimum of 7–10 days before initiation to avoid precipitating acute withdrawal.
- Use with caution in patients with moderate to severe hepatic impairment; contraindicated in acute hepatitis or liver failure.
- May cause injection-site reactions (e.g., pain, tenderness, induration); monitor and rotate sites.
- Not recommended for use in patients with acute renal impairment.
- Advise patients that Naltrexone will block the effects of exogenous opioids, including for analgesia.
Contraindications
- Patients receiving opioid analgesics, currently dependent on opioids, or in acute opioid withdrawal.
- Positive urine screen for opioids.
- Acute hepatitis or liver failure.
- History of hypersensitivity to Naltrexone or any component of the formulation.
Possible side effect
- Common: Nausea, headache, dizziness, insomnia, anxiety, injection-site reactions.
- Less common: Abdominal pain, vomiting, decreased energy, joint/muscle pain.
- Rare but serious: Hepatotoxicity, depression, suicidal ideation, eosinophilic pneumonia (injection), hypersensitivity reactions.
Drug interaction
- Opioid-containing medications (e.g., analgesics, antitussives): Naltrexone will block opioid effects; avoid concomitant use.
- Drugs with potential hepatotoxicity (e.g., acetaminophen, certain anticonvulsants): Increased risk of liver injury; monitor LFTs.
- Thioridazine: Reported interaction leading to lethargy and somnolence.
Missed dose
- Oral: If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose.
- Injection: Administer the next injection as soon as possible; do not administer two doses within 4 weeks.
Overdose
There is no specific antidote for Naltrexone overdose. Management is supportive and symptomatic. Hemodialysis is not expected to be effective due to high protein binding. In cases of suspected overdose, seek immediate medical attention.
Storage
- Store at 20°–25°C (68°–77°F); excursions permitted between 15°–30°C (59°–86°F).
- Protect from light.
- Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new medication or treatment regimen. Do not disregard professional medical advice or delay seeking it based on information provided here.
Reviews
“Prescribed Naltrexone as part of my recovery program. Combined with therapy, it drastically reduced my cravings and helped me stay committed to sobriety. The daily tablet was easy to incorporate into my routine.” – James L., patient.
“As a clinician, I have found Naltrexone to be an effective tool in reducing relapse rates among motivated patients with alcohol use disorder. The injectable form particularly improves compliance in long-term management.” – Dr. Elena Torres, Addiction Specialist.